Market Tracker

08/26 6:45pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

103.55
Delayed Data
As of Aug 26
 -0.10 / -0.10%
Today’s Change
79.66
Today|||52-Week Range
139.79
-4.49%
Year-to-Date

Today’s Trading

Previous close103.65
Today’s open103.43
Day’s range102.24 - 106.37
Volume261,513
Average volume (3 months)399,608
Market cap$2.2B
Dividend yield--
Data as of 3:59pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+2,064.46%
Earnings growth (this year)+2.30%
Earnings growth (next 5 years)+53.87%
Revenue growth (last year)+11.43%
P/E ratio9.4
Price/Sales32.00
Price/Book6.79

Competitors

 Today’s
change
Today’s
% change
GWPHGW Pharmaceuticals P...+0.09+0.11%
IRWDIronwood Pharmaceuti...+0.13+0.96%
PBYIPuma Biotechnology I...+0.68+1.19%
GLPGGalapagos NV+0.47+0.88%
Data as of 4:01pm ET, 08/26/2016

Financials

Next reporting dateOctober 31, 2016
EPS forecast (this quarter)$0.71
Annual revenue (last year)$71.9M
Annual profit (last year)$257.3M
Net profit margin357.80%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts